THE ORIGINS OF STERAMIST TECHNOLOGY
As an invention funded by a grant provided by the U.S. Defense Advanced Research Projects Agency (DARPA), ionized Hydrogen Peroxide (iHP) was developed as a direct response to weaponized anthrax attacks.
After the attacks, iHP began to establish itself in a more mainstream capacity with registration as a Hospital-Healthcare, general, and multiple-use disinfectant with exceptional efficacy against bacteria, bacterial spores, viruses, mold spores, and many other pathogens.
With iHP achievable solely through Binary Ionization Technology (BIT), the technology became the first combination of both solution and technology to be registered by the EPA as a Hospital-Healthcare and general-use disinfectant.
Binary Ionization Technology utilizes a solution comprised of 7.8% hydrogen peroxide as a sole active ingredient, naturally enhanced by a cold plasma arc. As a result, SteraMist application features superior material compatibility with a quick-acting disinfection and decontamination.
Independent testing had proven six-log (99.9999%) efficacy against the gold standard for sterilization, Geobacillus stearothermophilus and Bacillus atrophaeus - a notoriously difficult to kill spore. With this development, further EPA testing had placed it on the following Lists:
LIST G: Norovirus
LIST H: MRSA
LIST K: C. difficile spores
LIST L: Ebola
LIST M: H1N1
LIST N: Emerging Pathogens, Including SARS-CoV-2 Coronavirus
- H1N1 (Influenza A Virus)
- C. diff (Clostridium difficile) Spores
- Geobacillus Stearothermophilus Spores
- Mold & Mildew
....AND MANY MORE